Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Artificial Sweeteners Are Related to Non-Alcoholic Fatty Liver Disease: Microbiota Dysbiosis As a Novel Potential Mechanism Publisher



Emamat H1 ; Ghalandari H2 ; Tangestani H3, 4 ; Abdollahi A5 ; Hekmatdoost A2
Authors

Source: EXCLI Journal Published:2020


Abstract

Non-alcoholic fatty liver disease (NAFLD) is a systemic and wide-spread disease characterized by accumulation of excess fat in the liver of people who drink little or no alcohol. Artificial sweeteners (ASs) or sugar substitutes are food additives that provide a sweet taste, and are also known as low-calorie or non-calorie sweeteners. Recently people consume increasingly more ASs to reduce their calorie intake. Gut microbiome is a complex eco-system where 1014 microorganisms play several roles in host nutrition, bone mineralization, immune system reg-ulation, xenobiotics metabolism, proliferation of intestinal cells, and protection against pathogens. A disruption in composition of the normal microbiota is known as ‘gut dysbiosis’ which may adversely affect body metabo-lism. It has recently been suggested that dysbiosis may contribute to the occurrence of NAFLD. The aim of the present study was to investigate the effects of ASs on the risk of NAFLD. The focus of this review is on micro-biota changes and dysbiosis. Increasing evidence shows that ASs have a potential role in microbiota alteration and dysbiosis. We speculate that increased consumption of ASs can further raise the prevalence of NAFLD. However, further human studies are needed to determine this relationship definitively. © 2020, Leibniz Research Centre for Working Environment and Human Factors. All rights reserved.
Other Related Docs
4. Gut Microbiota in Nonalcoholic Fatty Liver Diseases With and Without Type-2 Diabetes Mellitus, European Journal of Gastroenterology and Hepatology (2021)
15. Diet-Microbiota Interactions: A New Approach to Personalized Nutrition, Journal of Mazandaran University of Medical Sciences (2021)
18. Role of Gut Microbiome in Polycystic Ovary Syndrome, Journal of Mazandaran University of Medical Sciences (2021)